Abstract
In general, from this double blind study of 204 infants it appeared that prenatal oral administration of vitamin K 1 exerted a beneficial effect on the relative deficiency of prothrombin that normally exists in the newborn infant. There was no evidence of undesirable side effects from doses of vitamin K 1 employed in this study. Bilirubin levels in the newborn infants receiving vitamin K 1 were not increased over the values in the placebo group. It is not possible to conclude from these data that such treatment is to be generally endorsed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have